Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

K Gao, R Wang, J Chen, L Cheng, J Frishcosy… - Chemical …, 2022 - ACS Publications
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …

The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies

VP Waman, N Sen, M Varadi, A Daina… - Briefings in …, 2021 - academic.oup.com
SARS-CoV-2 is the causative agent of COVID-19, the ongoing global pandemic. It has
posed a worldwide challenge to human health as no effective treatment is currently …

Natural compounds inhibit SARS-CoV-2 nsp13 unwinding and ATPase enzyme activities

A Corona, K Wycisk, C Talarico, C Manelfi… - ACS Pharmacology & …, 2022 - ACS Publications
SARS-CoV-2 infection is still spreading worldwide, and new antiviral therapies are an urgent
need to complement the approved vaccine preparations. SARS-CoV-2 nps13 helicase is a …

2D MXenes with antiviral and immunomodulatory properties: a pilot study against SARS-CoV-2

MA Unal, F Bayrakdar, L Fusco, O Besbinar, CE Shuck… - Nano Today, 2021 - Elsevier
Two-dimensional transition metal carbides/carbonitrides known as MXenes are rapidly
growing as multimodal nanoplatforms in biomedicine. Here, taking SARS-CoV-2 as a model …

Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort

A Zaliani, L Vangeel, J Reinshagen, D Iaconis… - Scientific data, 2022 - nature.com
Worldwide, there are intensive efforts to identify repurposed drugs as potential therapies
against SARS-CoV-2 infection and the associated COVID-19 disease. To date, the anti …

A blueprint for high affinity SARS-CoV-2 Mpro inhibitors from activity-based compound library screening guided by analysis of protein dynamics

J Gossen, S Albani, A Hanke, BP Joseph… - ACS pharmacology & …, 2021 - ACS Publications
The SARS-CoV-2 coronavirus outbreak continues to spread at a rapid rate worldwide. The
main protease (Mpro) is an attractive target for anti-COVID-19 agents. Unexpected …

A computational approach for the screening of potential antiviral compounds against SARS-CoV-2 protease: Ionic liquid vs herbal and natural compounds

J Saraswat, P Singh, R Patel - Journal of molecular liquids, 2021 - Elsevier
The current scenario across the globe shows unprecedented healthcare and an economic
crisis due to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) …

SARS‐CoV‐2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms

SI O'Donoghue, A Schafferhans, N Sikta… - Molecular systems …, 2021 - embopress.org
We modeled 3D structures of all SARS‐CoV‐2 proteins, generating 2,060 models that span
69% of the viral proteome and provide details not available elsewhere. We found that˜ 6% of …

MEDIATE-Molecular DockIng at homE: Turning collaborative simulations into therapeutic solutions

G Vistoli, C Manelfi, C Talarico, A Fava… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Collaborative computing has attracted great interest, enabling researchers
worldwide to come together and work seamlessly. Its relevance has never been so apparent …

Drug repositioning: A bibliometric analysis

G Sun, D Dong, Z Dong, Q Zhang, H Fang… - Frontiers in …, 2022 - frontiersin.org
Drug repurposing has become an effective approach to drug discovery, as it offers a new
way to explore drugs. Based on the Science Citation Index Expanded (SCI-E) and Social …